Literature DB >> 18784988

CCN3: Doctor Jekyll and Mister Hyde.

Bernard Perbal1.   

Abstract

CCN proteins are key regulators of signaling pathways that are essential for the control of normal life, from birth to death. As such, they make use of their unique mosaic structure to interact with several other regulatory proteins and ligands that control the fate of living cells. The various functions attributed to the CCN proteins may sometimes appear contradictory, but this situation reflects the complexity of the multimolecular scaffolds in which CCN proteins are engaged and the critical impact of the microenvironment that dictates the bioavailability of the elementary building blocks. CCN3 is one of the best examples of a CCN protein showing biological properties which may at first glance appear opposite or contradictory. Indeed, CCN3 acts both as a tumor suppressor and is associated with higher metastatic potential. Furthermore, the physical interaction of CCN3 with VEGF and its potential antiangionenic activity in glioma cells are in apparent contradiction with its proangiogenic activity in rabbit cornea. In this communication, I am revisiting the observations that led us to these apparent contradictions. After pointing out how the methodologies that were employed might have contributed to the confusion, I briefly discuss the dual biological activities of CCN3 in the context of tumor cell engineering and survival prognosis.

Entities:  

Year:  2008        PMID: 18784988      PMCID: PMC2570013          DOI: 10.1007/s12079-008-0028-0

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  24 in total

Review 1.  NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues.

Authors:  B Perbal
Journal:  Mol Pathol       Date:  2001-04

2.  Antiproliferative activity of CCN3: involvement of the C-terminal module and post-translational regulation.

Authors:  A M Bleau; N Planque; N Lazar; D Zambelli; A Ori; T Quan; G Fisher; K Scotlandi; B Perbal
Journal:  J Cell Biochem       Date:  2007-08-15       Impact factor: 4.429

3.  Inhibitory effect of CT domain of CCN3/NOV on proliferation and differentiation of osteogenic mesenchymal stem cells, Kusa-A1.

Authors:  Yuko Katsuki; Kei Sakamoto; Tokutaro Minamizato; Hatsune Makino; Akihiro Umezawa; Masa-Aki Ikeda; Bernard Perbal; Teruo Amagasa; Akira Yamaguchi; Ken-Ichi Katsube
Journal:  Biochem Biophys Res Commun       Date:  2008-02-12       Impact factor: 3.575

4.  Nuclear localisation of NOVH protein: a potential role for NOV in the regulation of gene expression.

Authors:  B Perbal
Journal:  Mol Pathol       Date:  1999-04

5.  Patterns of specific genomic alterations associated with poor prognosis in high-grade renal cell carcinomas.

Authors:  L Glukhova; E Angevin; C Lavialle; B Cadot; M J Terrier-Lacombe; B Perbal; A Bernheim; A F Goguel
Journal:  Cancer Genet Cytogenet       Date:  2001-10-15

6.  The expression of ccn3(nov) gene in musculoskeletal tumors.

Authors:  Maria Cristina Manara; Bernard Perbal; Stefania Benini; Rosaria Strammiello; Vanessa Cerisano; Stefania Perdichizzi; Massimo Serra; Annalisa Astolfi; Franco Bertoni; Jennifer Alami; Herman Yeger; Piero Picci; Katia Scotlandi
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

7.  novH: differential expression in developing kidney and Wilm's tumors.

Authors:  G Chevalier; H Yeger; C Martinerie; M Laurent; J Alami; P N Schofield; B Perbal
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

Review 8.  CCN proteins: multifunctional signalling regulators.

Authors:  Bernard Perbal
Journal:  Lancet       Date:  2004-01-03       Impact factor: 79.321

9.  CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family.

Authors:  Cristiane G Lin; Shr-Jeng Leu; Ningyu Chen; Christopher M Tebeau; Shao-Xia Lin; Cho-Yau Yeung; Lester F Lau
Journal:  J Biol Chem       Date:  2003-04-13       Impact factor: 5.157

10.  CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma.

Authors:  Viviana Vallacchi; Maria Daniotti; Francesca Ratti; Delia Di Stasi; Paola Deho; Annamaria De Filippo; Gabrina Tragni; Andrea Balsari; Antonino Carbone; Licia Rivoltini; Giorgio Parmiani; Noureddine Lazar; Bernard Perbal; Monica Rodolfo
Journal:  Cancer Res       Date:  2008-02-01       Impact factor: 12.701

View more
  12 in total

1.  It's a knockout: CCN3 suppresses neointimal thickening.

Authors:  Andrew Leask
Journal:  J Cell Commun Signal       Date:  2010-02-24       Impact factor: 5.782

2.  Flaws in the peer-reviewing process : a critical look at a recent paper studying the role of CCN3 in renal cell carcinoma.

Authors:  Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2012-08-03       Impact factor: 5.782

3.  CCN proteins: A centralized communication network.

Authors:  Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2013-02-19       Impact factor: 5.782

4.  Transforming growth factor β controls CCN3 expression in nucleus pulposus cells of the intervertebral disc.

Authors:  Cassie M Tran; Harvey E Smith; Aviva Symes; Laure Rittié; Bernard Perbal; Irving M Shapiro; Makarand V Risbud
Journal:  Arthritis Rheum       Date:  2011-10

5.  CCN2 expression and localization in melanoma cells.

Authors:  Wei Sha; Andrew Leask
Journal:  J Cell Commun Signal       Date:  2011-06-12       Impact factor: 5.782

6.  CCN notch signaling in vascular smooth muscle cells: good or bad?

Authors:  Jun-ichi Abe; Chen Yan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-04       Impact factor: 8.311

7.  Nephroblastoma overexpressed (NOV/CCN3) gene: a paired-domain-specific PAX3-FKHR transcription target that promotes survival and motility in alveolar rhabdomyosarcoma cells.

Authors:  Y Zhang; C Wang
Journal:  Oncogene       Date:  2011-03-21       Impact factor: 9.867

8.  CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor.

Authors:  L Wu; C Runkle; H-J Jin; J Yu; J Li; X Yang; T Kuzel; C Lee; J Yu
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

9.  CCN1 and CCN2: blood brothers in angiogenic action.

Authors:  Lester F Lau
Journal:  J Cell Commun Signal       Date:  2012-07-26       Impact factor: 5.782

Review 10.  Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review).

Authors:  Jun Li; Lin Ye; Sioned Owen; Hoi Ping Weeks; Zhongtao Zhang; Wen G Jiang
Journal:  Int J Mol Med       Date:  2015-10-23       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.